Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-067952

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Yakob Liawatidewi
Officer — SVP Corp Admin Center
Period of report
Nov 8, 2018
Accepted (ET)
Nov 13, 2018 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockNov 8, 2018M6,000$11.41A46,763D
Common StockNov 8, 2018S6,000$20.50D40,763D
Common StockNov 9, 2018M4,903$14.23A45,666D
Common StockNov 9, 2018M4,904$14.40A50,570D
Common StockF2Nov 9, 2018S11,808$21.2077D38,762D
Common StockF3holding———10,369ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F4$11.41Nov 8, 2018M6,000D—Mar 8, 2021Common Stock6,0000D
Stock Option (right to buy)F4$14.23Nov 9, 2018M4,903D—Dec 22, 2021Common Stock4,9030D
Stock Option (right to buy)F4$14.40Nov 9, 2018M4,904D—Apr 14, 2024Common Stock4,9040D

Explanation of responses